Pharma Mar (OTCMKTS:PHMMF) Sets New 1-Year Low – Here’s What Happened

Shares of Pharma Mar (OTCMKTS:PHMMF – Get Free Report) reached a new 52-week low during trading on Thursday. The stock traded as low as $77.09 and last traded at $77.09, with a volume of 360 shares changing hands. The stock had previously closed at $94.60.

Pharma Mar Price Performance

The stock has a 50 day simple moving average of $93.11 and a 200 day simple moving average of $93.31.

Pharma Mar Company Profile

(Get Free Report)

Pharma Mar, SA is a Spanish biopharmaceutical company focused on discovering, developing and commercializing innovative medicines derived from marine organisms. The company specializes primarily in oncology and maintains a research platform dedicated to identifying novel compounds with potential anticancer activity.

Its principal products include Yondelis (trabectedin), an anticancer treatment used in certain cases of advanced soft-tissue sarcoma and ovarian cancer, and Zepzelca (lurbinectedin), a therapy developed for patients with metastatic small-cell lung cancer whose disease has progressed during or after platinum-based chemotherapy.

Featured Stories

• Five stocks we like better than Pharma Mar
• 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
• Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
• Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
• The Factories Behind AI Servers Just Raised Their Outlooks—3 Contract Manufacturers to Watch